Sangamo BioSciences | SGMO - Los Ingresos Por Intereses





Los Ingresos Por Intereses Cambio Fecha
Alnylam Pharmaceuticals USD 26.6M 32K 2026-03
Bayer EUR 169M 39M 2025-12
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Compugen USD 1.14M 185K 2025-12
CSL USD 18M 1000K 2024-12
Gilead Sciences USD 95M 0 2026-03
GlaxoSmithKline GBP 22M 96M 2026-03
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
J&J USD 2.27 0.13 2026-06
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Merck USD 35M 34M 2026-03
Pfizer USD -0.04 115M 2026-06
Sanofi EUR 77M 17M 2026-06
Sarepta Therapeutics USD 7M 1.74M 2026-03
Tectonic Therapeutic USD 1.74M 217K 2024-12
Ultragenyx Pharmaceutical USD 6M 512K 2026-03
Vertex Pharmaceuticals USD 120.6M 5.8M 2026-06